Clinical trial
Impact of Switching COPD Patients From Inhaler Devices to the Omron C28P Nebuliser: a Prospective, Real-world Study
NCT06061679 is registered in ClinicalTrials.gov with Fondazione Policlinico Universitario Agostino Gemelli IRCCS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Switching COPD Patients From Inhaler Devices to the Omron C28P Nebuliser: a Prospective, Real-world Study
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 30, 2023
- Completion date
- January 31, 2025
- Enrollment
- 99 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
copd (chronic obstructive pulmonary disease) with acute lower respiratory infection